StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)

Close on Nov 18, 2026Market cap $7.13BP/E –Yield –

Cytokinetics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cytokinetics's operating income for the twelve months ending Jun 30, 2026 was -$707.91M. For fiscal 2025 it was -$612.26M. The highest annual figure on record is $26.10M in fiscal 2009.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$612.26M–
FY2024Dec 31, 2024-$536.25M–
FY2023Dec 31, 2023-$496.21M–
FY2022Dec 31, 2022-$324.20M–
FY2021Dec 31, 2021-$186.31M–
FY2020Dec 31, 2020-$93.94M–
FY2019Dec 31, 2019-$98.87M–
FY2018Dec 31, 2018-$88.92M–
FY2017Dec 31, 2017-$113.40M-706.8%
FY2016Dec 31, 2016$18.69M–
FY2015Dec 31, 2015-$37.41M–
FY2014Dec 31, 2014-$14.75M–
FY2013Dec 31, 2013-$33.89M–
FY2012Dec 31, 2012-$40.46M–
FY2011Dec 31, 2011-$47.96M–
FY2010Dec 31, 2010-$49.64M-290.2%
FY2009Dec 31, 2009$26.10M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$179.17M–
Q1 FY2026Mar 31, 2026-$183.62M–
Q4 FY2025Dec 31, 2025-$178.37M–
Q3 FY2025Sep 30, 2025-$166.76M–
Q2 FY2025Jun 30, 2025-$111.51M–
Q1 FY2025Mar 31, 2025-$155.63M–
Q4 FY2024Dec 31, 2024-$139.04M–
Q3 FY2024Sep 30, 2024-$140.80M–
Q2 FY2024Jun 30, 2024-$130.17M–
Q1 FY2024Mar 31, 2024-$126.24M–
Q4 FY2023Dec 31, 2023-$127.42M–
Q3 FY2023Sep 30, 2023-$122.27M–
Q2 FY2023Jun 30, 2023-$122.05M–
Q1 FY2023Mar 31, 2023-$124.47M–
Q4 FY2022Dec 31, 2022-$127.03M–
Q3 FY2022Sep 30, 2022-$108.44M–
Q2 FY2022Jun 30, 2022-$10.87M–
Q1 FY2022Mar 31, 2022-$77.86M–
Q4 FY2021Dec 31, 2021-$21.70M–
Q3 FY2021Sep 30, 2021-$69.20M-1434.9%
Q2 FY2021Jun 30, 2021-$54.80M–
Q1 FY2021Mar 31, 2021-$40.61M–
Q4 FY2020Dec 31, 2020-$36.41M–
Q3 FY2020Sep 30, 2020$5.18M–
Q2 FY2020Jun 30, 2020-$32.36M–
Q1 FY2020Mar 31, 2020-$30.36M–
Q4 FY2019Dec 31, 2019-$23.71M–
Q3 FY2019Sep 30, 2019-$23.93M–
Q2 FY2019Jun 30, 2019-$26.72M–
Q1 FY2019Mar 31, 2019-$24.52M–
Q4 FY2018Dec 31, 2018-$21.46M–
Q3 FY2018Sep 30, 2018-$17.91M–
Q2 FY2018Jun 30, 2018-$23.41M–
Q1 FY2018Mar 31, 2018-$26.13M–
Q4 FY2017Dec 31, 2017-$36.53M-575.1%
Q3 FY2017Sep 30, 2017-$28.42M-183.7%
Q2 FY2017Jun 30, 2017-$25.19M–
Q1 FY2017Mar 31, 2017-$23.25M–
Q4 FY2016Dec 31, 2016$7.69M–
Q3 FY2016Sep 30, 2016$33.97M–

More Cytokinetics figures

See a number that looks wrong?